A Comparison of Reported Gastrointestinal and Thromboembolic Events Between Rofecoxib and Celecoxib Using Observational Data

Author： Kasliwal Rachna  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.28, Iss.9, 2005-01, pp. : 803-816

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiovascular Events Associated with Long-Term Use of Celecoxib, Rofecoxib and Meloxicam in Taiwan: An Observational Study

By Huang Weng-Foung  

Drug Safety, Vol. 29, Iss. 3, 2006-01 ,pp. : 261-272

Adis International

Access to resources Recommend Favorite

More symptomatic upper GI events with rofecoxib than celecoxib

By  

Inpharma, Vol. 1, Iss. 1508, 2005-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

More symptomatic upper GI events with rofecoxib than celecoxib

By  

Reactions Weekly, Vol. 1, Iss. 1072, 2005-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Fewer GI complications with rofecoxib and celecoxib

By  

Inpharma, Vol. 1, Iss. 1240, 2000-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Celecoxib and rofecoxib ADRs compared with meloxicam

By  

Inpharma, Vol. 1, Iss. 1409, 2003-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite